نتایج جستجو برای: سلول های cd133

تعداد نتایج: 482993  

2012
Kumiko Hongo Shinsuke Kazama Eiji Sunami Nelson H. Tsuno Koki Takahashi Hirokazu Nagawa Joji Kitayama

CD133 has been identified as a putative cancer stem cell (CSC) marker in various cancers including colorectal cancer. The relation between CD133 expression and biological characteristics of colorectal cancer remains to be clarified. Protein expression of CD133 was immunohistochemically evaluated in surgical specimens of 225 patients with colorectal cancer who were treated by surgery, as well as...

ژورنال: :طب جنوب 0
غلامرضا خمیسی پور gholam reza khamisipour department of laboratory sciences, school of para medicine, bushehr university of medical sciences, bushehr, iranگروه علوم آزمایشگاهی، دانشکده پیراپزشکی، دانشگاه علوم پزشکی و خدمات بهداشتی درمانی بوشهر علی اکبر پور فتح اله ali akbar pourfathollah department of immunology, school of medical sciences, tarbiat modares university, tehran, iranگروه ایمنی شناسی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس مسعود سلیمانی masoud soleimani department of hematology, school of medical sciences, tarbiat modares university, tehran, iranگروه خون شناسی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس مهدی فروزنده مقدم mehdi fourouzandeh moghaddam department of biotechnology, school of medical sciences, tarbiat modares university, tehran, iranگروه بیوتکنولوژی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس مهرداد نوروزی نیا mehrdad norouzinia department of medical genetic, school of medical sciences, tarbiat modares university, tehran, iranگروه ژنتیک پزشکی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس سعید کاویانی said kavyani department of hematology, school of medical sciences, tarbiat modares university, tehran, iranگروه خون شناسی، دانشکده علوم پزشکی، دانشگاه تربیت مدرس کامران علی مقدم

زمینه: تبدیل اپی ژنتیکی سلول های سوماتیک مختص بیمار به سلول های رویانی به دلیل اهمیت آن در پیوند سلول های بنیادی و سازگاری با گیرنده ازارزش بسیاری برخوردار است. با این حال، به کارگیری درمانی سلول های به دست آمده به دلیل مشکلات فنی و موضوعات اخلاقی امکان پذیر نیست. اخیرا روش های جدیدی مطرح شده که با بیان اکتوپیک فاکتورهای رونویسی دوره رویانی سلول سوماتیک را به سلول شبه رویانی تبدیل کرده اند. محد...

Journal: :Circulation 2005
Sergey V Shmelkov Sarah Meeus Nelson Moussazadeh Pouneh Kermani William K Rashbaum Sina Y Rabbany Marilee A Hanson William J Lane Ryan St Clair Kathryn A Walsh Sergio Dias Jason T Jacobson Barbara L Hempstead Jay M Edelberg Shahin Rafii

BACKGROUND CD133 (AC133) is a surface antigen that defines a broad population of stem cells, including myogenic and endothelial progenitors. CD133+ cells are rare in adult tissues, and the factors that support their differentiation into mature angiomyogenic cells are not known. These hurdles have hampered the use of CD133+ cells for therapeutic purposes. Because human fetal liver is a rich sour...

Journal: :PLoS ONE 2009
Susan Friedman Min Lu Atara Schultz Dolly Thomas Reigh-Yi Lin

BACKGROUND Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies. Its rapid onset and resistance to conventional therapeutics contribute to a mean survival of six months after diagnosis and make the identification of thyroid-cancer-initiating cells increasingly important. METHODOLOGY/PRINCIPAL FINDINGS In prior studies of ATC cell lines, CD133(+) cells exhibited stem-ce...

2013
Yanhong Deng Manal M. Hassan Jianwen Mo Edward H. Lin

BACKGROUND CD133 is a marker that identifies/enriches cancer stem cell implicated in tumor initiation. We hypothesize that changes in the CD133 mRNA expression levels and vascular endothelial growth factor (VEGF) may correlate tumor response in GIST. METHODOLOGY/PRINCIPAL FINDINGS After informed consent, we obtained peripheral blood samples from 24 evaluable patients with gastrointestinal str...

Journal: :Cancer research 2007
Cosima V Pfenninger Teona Roschupkina Falk Hertwig Denise Kottwitz Elisabet Englund Johan Bengzon Sten Eirik Jacobsen Ulrike A Nuber

Human brain tumor stem cells have been enriched using antibodies against the surface protein CD133. An antibody recognizing CD133 also served to isolate normal neural stem cells from fetal human brain, suggesting a possible lineage relationship between normal neural and brain tumor stem cells. Whether CD133-positive brain tumor stem cells can be derived from CD133-positive neural stem or progen...

2017
Yeonhwa Song Jaewoo Jang Tae-Hoon Shin Sang Mun Bae Jin-sun Kim Kang Mo Kim Seung-Jae Myung Eun Kyung Choi Haeng Ran Seo

BACKGROUND CD133-positive cells in hepatocellular carcinoma (HCC) exhibit cancer stem cell (CSC)-like properties as well as resistance to chemotherapeutic agents and ionizing radiation; however, their function remains unknown. In this paper, we identified a hitherto unknown mechanism to overcome CD133-induced resistance to anticancer therapy. METHODS We applied an alternative approach to enri...

Journal: :The Journal of clinical investigation 2008
Mark A LaBarge Mina J Bissell

The concept of the so-called cancer stem cell (CSC) holds that only a minority of cells within a tumor have the ability to generate a new tumor. Over the last decade, a large body of literature has implicated the protein CD133 as a marker of organ-specific adult stem cells and in some cancers as a bona fide CSC marker. In this issue of the JCI, Shmelkov et al. challenge the view that CD133 is a...

Journal: :PLoS ONE 2008
Corinne E. Griguer Claudia R. Oliva Eric Gobin Pascale Marcorelles Dale J. Benos Jack R. Lancaster G. Yancey Gillespie

Mitochondria dysfunction and hypoxic microenvironment are hallmarks of cancer cell biology. Recently, many studies have focused on isolation of brain cancer stem cells using CD133 expression. In this study, we investigated whether CD133 expression is regulated by bioenergetic stresses affecting mitochondrial functions in human glioma cells. First, we determined that hypoxia induced a reversible...

Journal: :European review for medical and pharmacological sciences 2009
M A Puglisi A Sgambato N Saulnier F Rafanelli M Barba A Boninsegna A C Piscaglia C Lauritano M L Novi F Barbaro E Rinninella C Campanale F Giuliante G Nuzzo S Alfieri G B Doglietto A Cittadini A Gasbarrini

BACKGROUND "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsible for tumor initiation, maintenance and spreading. Although a universal marker for CSC has not yet been identified, CD133 has been proposed as the hallmark of CSC in colon cancer. The aim of our study was to assess the presence of a CD133+ cell fraction in samples of colon cancer and liver metastas...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید